| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 11/29/2006 | EP1726643A1 Method for the provision, identification and selection of proteases with altered sensitivity to activity-modulating substances |
| 11/29/2006 | EP1726640A1 Rat embryonic stem cell |
| 11/29/2006 | EP1726637A1 Novel transformant and process for producing polyester by using the same |
| 11/29/2006 | EP1726313A1 Drug for preventing and treating arteriosclerosis |
| 11/29/2006 | EP1726311A2 Migration of hematopoietic stem cells and progenitor cells to the liver |
| 11/29/2006 | EP1726208A1 Murine stem cells and applications thereof |
| 11/29/2006 | EP1725682A1 Methods and compositions for generating and amplifying dna libraries for sensitive detection and analysis of dna methylation |
| 11/29/2006 | EP1725668A1 Genetically modified plants and their applications in phytoremediation. |
| 11/29/2006 | EP1725667A1 Plants with increased activity of multiple starch phosphorylating enzymes |
| 11/29/2006 | EP1725666A2 Plants with reduced activity of the starch phosphorylating enzyme phosphoglucan, water dikinase |
| 11/29/2006 | EP1725665A2 Plants with increased activity of a starch phosphorylating enzyme |
| 11/29/2006 | EP1725664A1 Thiol methyltransferase-based selection |
| 11/29/2006 | EP1725663A1 Gamma-butyrobetaine hydroxylase originated from neurospora crassa |
| 11/29/2006 | EP1725662A1 Infectious aetiology of prostatic disease and methods to identify causative agents |
| 11/29/2006 | EP1725661A1 Polynucleotides for the detection of escherichia coli o157 |
| 11/29/2006 | EP1725660A2 Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| 11/29/2006 | EP1725659A2 Natural igm antibodies and inhibitors thereof |
| 11/29/2006 | EP1725658A2 Materials and methods for treatment of allergic disease |
| 11/29/2006 | EP1725657A1 Prostatic acid phosphatase antigens |
| 11/29/2006 | EP1725584A1 Novel phytochrome-interacting protein and a use thereof |
| 11/29/2006 | EP1725266A2 Potent mucosal immune response induced by modified immunomodulatory oligonucleotides |
| 11/29/2006 | EP1725260A1 Vaccine for preventing and/or treating a herpes virus infection |
| 11/29/2006 | EP1725257A1 Chicken anemia virus vaccine from cell line |
| 11/29/2006 | EP1725255A2 Polypeptides for inducing a protective immune response against staphlococcus aureus |
| 11/29/2006 | EP1725216A2 Immunoliposome-nucleic acid amplication (ilnaa) assay |
| 11/29/2006 | EP1725112A2 Cell display libraries |
| 11/29/2006 | EP1725091A1 Generation of transgenic avians |
| 11/29/2006 | EP1629093A4 Glycerol-3-phosphate phosphatase and glycerol-3-phosphate dehydrogenase from candida albicans, genes encoding the same, vector and host cell containing the genes, and method for producing glycerol using the host cell |
| 11/29/2006 | EP1558758A4 Molecular identification of aspergillus species |
| 11/29/2006 | EP1531677A4 Three dimensional vaginal tissue model containing immune cells |
| 11/29/2006 | EP1497656B1 Diagnosis of carcinoma using raig1 polypeptides |
| 11/29/2006 | EP1478774A4 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 11/29/2006 | EP1470152A4 Peptides for increasing transfection efficiency |
| 11/29/2006 | EP1434993A4 Methods of assaying connective tissue growth factor |
| 11/29/2006 | EP1412517B1 Methods, kits and compositions of combination oligomers |
| 11/29/2006 | EP1392860A4 Molecular detection chip including mosfet, molecular detection device employing the chip, and molecular detection method using the device |
| 11/29/2006 | EP1390545B1 Device and biological sample processing methods |
| 11/29/2006 | EP1390544B1 Universal multi-variant detection system |
| 11/29/2006 | EP1385860B1 Immobilization of oligonucleotides onto solid supports |
| 11/29/2006 | EP1375656B1 Novel protein and dna encoding the same |
| 11/29/2006 | EP1373573A4 Conjugate probes and optical detection of analytes |
| 11/29/2006 | EP1373497B1 Method for increasing the production of an antibiotic in a bacterium by introducing mutations that confer antibiotic-resistance |
| 11/29/2006 | EP1360296B1 Method for the production of plant seed with modified fibre content and modified seed coat |
| 11/29/2006 | EP1353953B1 Mu-1, member of the cytokine receptor family |
| 11/29/2006 | EP1306440B1 Method of improving gene transfer efficiency into plant cells |
| 11/29/2006 | EP1306435B1 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin |
| 11/29/2006 | EP1301614B1 Codon-optimized papilloma virus sequences |
| 11/29/2006 | EP1290164B1 Human twik-8 molecules and uses thereof |
| 11/29/2006 | EP1268828B1 Signal transduction stress-related protein and use in plants |
| 11/29/2006 | EP1248804B1 Recombinant antibodies to human interleukin-1 beta |
| 11/29/2006 | EP1248650B1 Improved dna vaccines for bovine herpesvirus-1 |
| 11/29/2006 | EP1221489B1 Regulatory sequences functioning in filamentous fungi |
| 11/29/2006 | EP1220911B1 P-glycoproteins and uses thereof |
| 11/29/2006 | EP1206529B1 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 11/29/2006 | EP1196598B1 Dsp-3 dual-specificity phosphatase |
| 11/29/2006 | EP1162999B1 Vaccine against Streptococcus pneumoniae |
| 11/29/2006 | EP1141026B1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 11/29/2006 | EP1135472B1 UDP-N- ACETYL GLUCOSAMINE: GALACTOSE-BETA1, 3-N- ACETYL GALACTOSAMINE-ALPHA-R/ N- ACETYL GLUCOSAMINE -BETA1, 3-N- ACETYL GALACTOSAMINE- ALPHA-R (GlcNAc TO GalNAc) BETA1, 6-N- ACETYL GLUCOSAMINYL TRANSFERASE, C2/4GnT |
| 11/29/2006 | EP1117801B1 Polyketide synthase enzymes and recombinant dna constructs therefor, for the production of compounds related to fk-506 and fk-520 |
| 11/29/2006 | EP1117692B1 Tie2 agonist antibodies |
| 11/29/2006 | EP1114861B1 Ly6h gene |
| 11/29/2006 | EP1092027B1 Therapeutic and diagnostic domain 1 beta 2 gp1 polypeptides and methods of using same |
| 11/29/2006 | EP1088076B1 METHOD FOR OBTAINING RECOMBINANT HBsAg |
| 11/29/2006 | EP1088066B1 Antisense oligonucleotide constructs based on beta-arabinofuranose and its analogues |
| 11/29/2006 | EP1068331B1 Medicaments for inducing cytotoxic t-cells |
| 11/29/2006 | EP1026246B1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same |
| 11/29/2006 | EP1019517B1 Production of proteins in plant seeds |
| 11/29/2006 | EP1012281B1 Human leukocyte calcium activated potassium channel polypeptide |
| 11/29/2006 | EP0991781B1 Group of nucleic acid molecules for salmonella detection, nucleic acids, kit and use |
| 11/29/2006 | EP0952223B1 REGULATORY SEQUENCE OF CELLULASE cbh1 GENES ORIGINATING IN TRICHODERMA VIRIDE AND SYSTEM FOR MASS-PRODUCING PROTEINS OR PEPTIDES THEREWITH |
| 11/29/2006 | EP0948624B1 Mutants of streptococcal toxin a and methods of use |
| 11/29/2006 | EP0931151B1 Thermostable nucleic acid polymerase from thermococcus gorgonarius |
| 11/29/2006 | EP0918848B1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna |
| 11/29/2006 | EP0915982B1 Drosophila melanogaster p70 s6 kinase |
| 11/29/2006 | EP0915981B1 Isolation of the biosynthesis genes for pseudo-oligosaccharides from streptomyces glaucescens gla.o and their use |
| 11/29/2006 | EP0864648B1 Method for screening compounds regulating the expression of human-inducible nitric oxide synthase |
| 11/29/2006 | EP0837936B1 New immunoregulatory protein lst-1 |
| 11/29/2006 | EP0821695B1 Antibody purification by low-ph hydrophobic interaction chromatography |
| 11/29/2006 | EP0788546B1 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 11/29/2006 | EP0785716B1 Cytokine designated lerk-6 |
| 11/29/2006 | EP0719336B1 Modified plant viruses as vectors of heterologous peptides |
| 11/29/2006 | EP0556292B2 Hepatitis c virus asialoglycoproteins |
| 11/29/2006 | CN1871514A Bio-assay substrate having a power supply wire configuration |
| 11/29/2006 | CN1871361A Method of judging inflammatory disease by using single nucleotide polymorphism in galectin-2 gene |
| 11/29/2006 | CN1871360A Method of detecting regulation effect of synoviolin activity |
| 11/29/2006 | CN1871359A Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 11/29/2006 | CN1871357A Compositions and methods for altering biosynthesis of taxanes and taxane-related compounds |
| 11/29/2006 | CN1871356A Retroviral virus vectors for delivery of interfering rna |
| 11/29/2006 | CN1871355A Method for the recovery of non-segmented, nagative-stranded rna viruses from cdna |
| 11/29/2006 | CN1871354A Cotton alpha-globulin promoter for seed-specific expression of transgenes |
| 11/29/2006 | CN1871353A Fatty acid desaturases from primula |
| 11/29/2006 | CN1871352A Compositions and methods for regulating polysaccharides of a plant cell |
| 11/29/2006 | CN1871351A Novel fungal proteins and nucleic acids encoding same |
| 11/29/2006 | CN1871350A Nucleic acids useful for triggering tumor cell lethality |
| 11/29/2006 | CN1871349A Method and kit for estimating side effect by paclitaxel therapy |
| 11/29/2006 | CN1871348A Nucleic acid-adsorbing porous membrane for separating and purifying nucleic acid and apparatus for separating and purifying nucleic acid |
| 11/29/2006 | CN1871347A Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in |
| 11/29/2006 | CN1871346A Engineering single-gene-controlled staygreen potential into plants |
| 11/29/2006 | CN1871341A Methods for enhancing embryo viability |
| 11/29/2006 | CN1871259A Improved antibodies having altered effector function and methods for making the same |